Cutler Group LP Edwards Lifesciences Corp Call Options Transaction History

Cutler Group LP

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	SELL	$74.26 - $84.51 $81,686 - $92,961	-1,100 Reduced 73.33%	400 $0
Q4 2022 Feb 07, 2023	SELL	$68.3 - $87.44 $116,110 - $148,648	-1,700 Reduced 53.13%	1,500 $0
Q3 2022 Oct 25, 2022	SELL	$82.37 - $107.29 $247,110 - $321,870	-3,000 Reduced 48.39%	3,200 $2,000
Q2 2022 Aug 04, 2022	SELL	$86.5 - $128.27 $112,450 - $166,751	-1,300 Reduced 17.33%	6,200 $17,000
Q1 2022 Apr 14, 2022	BUY	$101.96 - $128.34 $764,700 - $962,550	7,500 New	7,500 $47,000
Q3 2021 Oct 26, 2021	SELL	$102.91 - $122.75 $277,857 - $331,425	-2,700 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$83.84 - $104.76 $251,520 - $314,280	-3,000 Reduced 52.63%	2,700 $10,000
Q1 2021 Apr 26, 2021	BUY	$78.68 - $90.67 $448,476 - $516,819	5,700 New	5,700 $18,000
Q1 2020 May 07, 2020	SELL	$52.41 - $81.0 $183,435 - $283,500	-3,500 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$61.55 - $75.43 $92,325 - $113,145	-1,500 Reduced 30.0%	3,500 $12,000
Q2 2019 Aug 09, 2019	SELL	$55.74 - $64.41 $55,740 - $64,410	-1,000 Reduced 16.67%	5,000 $3,000
Q1 2019 May 10, 2019	SELL	$47.89 - $64.05 $43,101 - $57,645	-900 Reduced 13.04%	6,000 $16,000
Q4 2018 Feb 05, 2019	BUY	$46.41 - $56.94 $255,254 - $313,170	5,500 Added 392.86%	6,900 $35,000
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $70,661 - $90,155	-1,900 Reduced 57.58%	1,400 $30,000
Q4 2017 Jan 17, 2018	SELL	$33.79 - $39.39 $1.1 Million - $1.28 Million	-32,500 Reduced 90.78%	3,300 $35,000
Q3 2017 Oct 17, 2017	BUY	$36.29 - $38.83 $1.3 Million - $1.39 Million	35,800	35,800 $40,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.